Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Public ClinicalTrials.gov record NCT00622726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial
Study identification
- NCT ID
- NCT00622726
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
- Conventional Laser for ROP Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 4 Weeks to 22 Weeks
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2020
- Last update posted
- Jun 5, 2017
2008 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Huntington Memorial Hospital | Pasadena | California | 91109 | — |
| Presbyterian-St. Luke's Hospital | Denver | Colorado | 80218 | — |
| OSF St. Francis Medical Center-Children's Hospital of Illinois | Peoria | Illinois | 61637 | — |
| Palmetto Health Richland Hospital | Columbia | South Carolina | 29203 | — |
| Palmetto Health Baptist Hospital | Columbia | South Carolina | 29223 | — |
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | — |
| Baylor University Medical Center | Dallas | Texas | 75346 | — |
| Las Palmas Medical Center | El Paso | Texas | 79902 | — |
| R.E. Thomason Hospital | El Paso | Texas | 79905 | — |
| Del Sol Medical Center | El Paso | Texas | 79925 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| St. Joseph Medical Center | Houston | Texas | 77002 | — |
| Children's Memorial Hermann Hospital | Houston | Texas | 77030 | — |
| Memorial Hermann Southwest Hospital | Houston | Texas | 77074 | — |
| Clear Lake Regional Medical Center | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00622726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00622726 live on ClinicalTrials.gov.